Addiction News and Research

RSS

In a nation growing hostile toward drugs and homelessness, Los Angeles tries leniency

Inside a bright new building in the heart of Skid Row, homeless people hung out in a canopy-covered courtyard — some waiting to take a shower, do laundry, or get medication for addiction treatment.

8 Jul 2025

Transforming OCD treatment through research and innovation

Obsessive-compulsive disorder (OCD) impacts approximately 2% of the global population, often preventing individuals from living life to their full potential.

2 Jul 2025

Quitting smoking in addiction recovery made easier with tailored support

For people recovering from substance use disorders, quitting smoking remains one of the most difficult-but most crucial-steps toward long-term health.

1 Jul 2025

Most Medicaid plans cover naloxone but barriers still exist

A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose reversal drug naloxone, although certain restrictions and quantity limits may still prevent people from accessing this life-saving drug.

27 Jun 2025

Flexible wireless implant offers hope for chronic pain sufferers

Chronic pain is a debilitating condition that severely impacts quality of life, often leading to reliance on opioid medications with their severe side effects and addiction risks.

24 Jun 2025

Study identifies strategies for expanding low-barrier wound care services for people who use drugs

A new study published in the Harm Reduction Journal identifies critical factors and strategies for expanding low-barrier wound care services for people who use drugs (PWUD).

19 Jun 2025

Addictive screen use linked to poor mental health in preteens

Addictive use of social media, video games, or mobile phones-but not total screen time-is associated with worse mental health among preteens, a new study by researchers at Columbia and Cornell universities has found.

19 Jun 2025

OU researchers launch innovative study to track e-cigarette habits in young adults

Electronic cigarettes, or vapes, are widely used and available in hundreds of different types and flavors, yet researchers lack information about the everyday e-cigarette habits of young adults.

18 Jun 2025

Rising homelessness among pregnant and parenting people in Canada

Homelessness is increasing in pregnant and parenting people in Canada, posing health risks to children. Authors of a commentary in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241623 argue it is a health crisis that needs urgent attention.

16 Jun 2025

Digital classroom lessons give students the tools to say no to vaping

Researchers co-designed and user-tested the ‘OurFutures Vaping’ digital program to prevent e-cigarette use among Australian adolescents. The four-lesson intervention, developed with students and teachers, showed high acceptability and addresses critical gaps in youth vaping prevention.

12 Jun 2025

Telehealth does not increase risk of substance use disorder in ADHD patients

Telehealth can make health care easier to access for patients with attention-deficit/hyperactivity disorder (ADHD) who need treatment, but experts worry about an increased risk of substance use disorder for patients being prescribed controlled medications such as stimulants for ADHD during these appointments.

12 Jun 2025

Non-prescribed ketamine use rises sharply across the UK

The rise in non-prescribed ketamine use across the UK in recent years is a cause for concern, say doctors in The BMJ today.

12 Jun 2025

Protein ELAV identified as key regulator of circular RNAs in the brain

Deep within our nerve cells, a molecule is at work that has no beginning and no end. Instead of a straight chain, as is it common for most RNA strands, it forms a closed loop.

10 Jun 2025

Weight loss drug semaglutide proven safe and effective for people with schizophrenia

Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University of Queensland researchers have found.

10 Jun 2025

Dr. Stephen Ross’s research into psychedelic medicine expands therapeutic frontiers

In a comprehensive Genomic Press Interview published today, Dr. Stephen Ross, a leading figure in psychedelic medicine at New York University (NYU), reveals how a serendipitous conversation in 2006 launched his journey into investigating psychedelic compounds as potential breakthrough treatments for some of psychiatry's most challenging conditions.

10 Jun 2025